At Prime Skin & Laser, our priority is to provide personalized, safe, and effective solutions tailored to your unique health needs
Orforglipron had a similar safety profile as other GLP-1 receptor agonists. Trial outcomes For ATTAIN-2, researchers enrolled 1,613 adults aged 18 years and older with obesity or overweight plus one weight-related comorbidity, and with type 2 diabetes with an HbA1c between 7% and 10% at baseline (mean age, 56.8 years
doi: 10.1016/S0021-9258(18)42531-8
For example, Lonza, in October 2023, announced the extension of a collaboration with a major biopharmaceutical partner for commercial-scale filling of antibody-drug conjugates (ADCs)
Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN- Production via Suppressing JAK-STAT Pathway
These medications work by slowing digestion to increase fullness and reduce food cravings